Lanean...
Spotlight on perampanel in the management of seizures: design, development and an update on place in therapy
PURPOSE: Perampanel is a first-in-class antiepileptic medication approved for the treatment of partial (focal) seizures, and as adjunctive treatment for primarily generalized tonic–clonic seizures. The pharmacology, efficacy data, adverse-effect profile, pharmacokinetics and place in therapy are rev...
Gorde:
| Argitaratua izan da: | Drug Des Devel Ther |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5634370/ https://ncbi.nlm.nih.gov/pubmed/29042752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S122404 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|